Navigation Links
The Alliance for Lupus Research announces 2008 grantees
Date:4/17/2008

The Alliance for Lupus Research (ALR) recently announced it will award nearly $7 million to researchers around the world. The ALR is very proud to announce, during National Minority Health Month, that with our 2008 class of grantees the ALR has funded more than 100 research projects, and committed more than $50 million to research, since our founding in 1999, says ALR President Barbara Boyts. For a full list of grantees, visit the ALRs website, www.lupusresearch.org.

Twenty-seven projects will be funded through ALRs Target Identification in Lupus (TIL) and Pilot Grant programs. TIL investigators receive a two-year, up-to-$500,000 award for research focused on removing the barriers to new treatments and a possible cure. All research funded under the TIL program is based on realizable goals for translation into therapeutic discovery programs that is, research that can move quickly from the laboratory to the patients bedside. Pilot Grant investigators receive a one-year award of up to $75,000. The Pilot Grant program is designed to support efforts that reflect innovative approaches and techniques and aid in the development of necessary pilot data for submission of larger awards to National Institutes of Health, the ALR, or other funding agencies.

Lupus causes unpredictable symptoms ranging from fatigue and joint pain to severe organ damage and, too often, can be fatal. Women are nine times more likely than men to develop the condition. Women of African-American descent are three times more likely to be diagnosed with the disease. Asian, Hispanic and women from the Pacific Rim are also more likely to be affected. African-American women, aged 45 to 64, not only have the highest death rate of people with lupus, but also have the biggest increase in death rates over the past 20 years, according to Dr. Charles Helmick, the Center for Disease Controls Medical Epidemiologist.

Lupus is a sever
'/>"/>

Contact: Sam Rogers
srogers@lupusresearch.org
646-522-1902
Alliance for Lupus Research
Source:Eurekalert

Page: 1 2

Related biology news :

1. Launching a global alliance for pharmacogenomics
2. New UEA-Cefas alliance launched
3. KAUST announces academic excellence alliance partnership with Imperial College London
4. Alliance for a Green Revolution in Africa commits 180M to revive farmers depleted soils
5. Genetic Alliance names Genetic Testing as its official journal
6. Cogent Systems and Northrop Grumman Reach Agreement to Settle Automated Fingerprint Identification Technology Suit and Create Strategic Alliance
7. Cogent Systems and Northrop Grumman Reach Agreement to Settle Automated Fingerprint Identification Technology Suit and Create Strategic Alliance
8. Prions and retroviruses -- an unholy alliance?
9. Genes linked with lupus are revealed, giving hope for new treatments
10. DNA variations signal lupus risk
11. UT Southwestern secures $5 million NIH grant for lupus research
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4